Through a bioinformatics interrogation of mRNA expression levels of all SMYD family members in breast cancer samples, Song et al. identified that SMYD3 was significantly upregulated in breast cancer patients in 27 different databases [44]. Here, SMYD3 is linked to breast cancer.